Of the 14 melanoma hallmark genes evaluated in the prevalence cohort (including PTPRJ), an additional 24 putatively pathogenic somatic mutations were identified in seven genes–NRAS, TP53, PTPRJ, KIT, KRAS, GNA11, and BAP1 (S4 Table). This evidence concerns the gene KIT and melanoma.